Zydus Amplitude receives CE mark for robotic surgical system 'Andy'

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2025-11-13 09:07 GMT | Update On 2025-11-13 09:07 GMT

Ahmedabad: Amplitude Surgical, a wholly owned subsidiary of Zydus MedTech France SAS, a wholly owned subsidiary of Zydus Lifesciences Ltd, a life sciences company with an international presence has announced that its robotic surgical system “Andy” has received CE mark approval.

This confirms its compliance with European standards for safety, performance, and quality.

‘Andy’ is built with its proprietary navigation platform, Amplivision. The CE-marked solution integrates Amplitude’s navigation technology with robotic assistance, developed through a strategic collaboration with eCential Robotics.

Speaking on this development, Dr. Sharvil P. Patel, Managing Director, Zydus Lifesciences Ltd., said, "This milestone reflects our commitment to innovation that is both patient-centric and future-ready. Andy represents a convergence of science, healthcare, and technology, I extend my heartfelt congratulations to the Amplitude R&D team for their unwavering dedication and scientific excellence in bringing this breakthrough to life."

Andy is a collaborative robot built on proprietary technology capable of performing bone resections with precision and reliability.

Andy delivers enhanced accuracy and consistency, enabling optimal alignment while minimizing tissue trauma which is intended to result in smaller incisions, reduced pain, faster recovery, and fewer complications, ultimately enhancing knee function, shortening hospital stays, and ensuring long-term implant performance.

Read also: Zydus bags Health Canada approval for Mesalamine suppositories for active ulcerative proctitis

Earlier this year, Zydus MedtTech expanded its global presence with the strategic acquisition of Amplitude Surgical a European MedTech company specializing in high-quality lower-limb orthopaedic technologies.

Read also: Zydus gets USFDA Orphan Drug Designation for Desidustat for beta-thalassemia

Zydus Lifesciences Ltd. is a global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. Over the last decade, Zydus has introduced several products in the market for treating unmet healthcare needs with vaccines, therapeutics, biologicals and New Chemical Entities.

Read also: Zydus gets China NMPA nod for Major Depressive Disorder drug Venlafaxine ER

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Zydus Amplitude receives CE mark for robotic surgical system 'Andy'

Similar News

Knee Implant Prices Under Fresh Review: NPPA Weighs 10% Hike Request from Manufacturers

Ziller Medical Denied Manufacturing Nod for Cervical Cerclage Pessary Over Inadequate Safety Data

Low-Risk Medical Device Makers Get Clarity: CDSCO Publishes Class A Risk Classification List under MDR 2017

One Label, One Rule: Centre Harmonises Legal Metrology Norms with Medical Device Standards

India launches MAHA-MedTech mission to boost self-reliance in Medical Technology

Modi Mundipharma Gets SEC Approval to Study Cingal, a Hyaluronic Acid-Steroid Device for Osteoarthritis Knee Pain

Johnson & Johnson MedTech launches Total Shoulder Replacement System